Bioanalytical Systems Inc. | Mutual Funds
Mutual Funds that own Bioanalytical Systems Inc.
Bridgeway Ultra Small Company Fund
164,510
1.61%
139,900
0.26%
12/31/2017
Vanguard Extended Market Index Fund
111,396
1.09%
0
0%
07/31/2018
Vanguard Total Stock Market Index Fund
92,933
0.91%
0
0%
07/31/2018
Bridgeway Omni Small Cap Value Fund
10,000
0.1%
0
0%
12/31/2017
Fidelity Spartan Extended Market Index Fund
4,687
0.05%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
4,047
0.04%
0
0%
09/06/2018
Bridgeway Omni Tax Managed Small Cap Value Fund
4,000
0.04%
0
0%
12/31/2017
2,172
0.02%
0
0.01%
09/05/2018
| Address |
2701 Kent Avenue
West Lafayette Indiana 47906
United States
|
|
Employees
|
- |
| Website |
http://www.basinc.com |
| Updated |
07/08/2019 |
| Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company operates through through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. |
